BioNTech SE (BNTX) Interest Coverage Ratio (2018 - 2025)
BioNTech SE (BNTX) posted Interest Coverage Ratio of 76.86 for Q4 2025, up 4029.64% sequentially from 1.86 in Q3 2025, and up 751.68% YoY from 9.02 in Q4 2024.
BioNTech SE (BNTX) Interest Coverage Ratio (2018 - 2025) Analysis & Trends
BioNTech SE has reported Interest Coverage Ratio for 8 years, with the latest figure at 76.86 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 751.68% year-over-year to 76.86 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 20.01 (down 50.41% YoY) and the FY2025 annual result came in at 20.13, up 58.04% from the prior year.
- Interest Coverage Ratio advanced to 76.86 in Q4 2025 per BNTX's latest filing, from 1.86 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 433.31 in Q2 2023 and troughed at 819.43 in Q2 2022.
- A 5-year average of 82.31 and a median of 0.66 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio tumbled 2686283.81% in 2022, then surged 751.68% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 0.0 in 2021, then sank by 2686283.81% to 20.7 in 2022, then fell by 0.89% to 20.88 in 2023, then jumped by 43.52% to 11.79 in 2024, then soared by 751.68% to 76.86 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 76.86, 1.86, and 71.59 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 4.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76.86 |
| Sep 30, 2025 | 1.86 |
| Jun 30, 2025 | 71.59 |
| Mar 31, 2025 | 15.76 |
| Dec 31, 2024 | -11.79 |
| Sep 30, 2024 | -1.31 |
| Jun 30, 2024 | 132.36 |
| Mar 31, 2024 | 107.91 |
| Dec 31, 2023 | -20.88 |
| Sep 30, 2023 | -36.55 |
| Jun 30, 2023 | 433.31 |
| Mar 31, 2023 | -22.57 |
| Dec 31, 2022 | -20.70 |
| Sep 30, 2022 | -742.14 |
| Jun 30, 2022 | -819.43 |
| Mar 31, 2022 | -814.49 |
| Dec 31, 2021 | -770.44 |
| Sep 30, 2021 | -57.12 |
| Jun 30, 2021 | 23.87 |
| Mar 31, 2021 | 37.19 |